Navigation Links
Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates

MOUNTAIN VIEW, Calif., May 12 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) reported today financial results for its fiscal quarter ended March 31, 2008 and provided an update on the Company's progress with its product candidates. The net loss for the 2008 first fiscal quarter, as reported in accordance with accounting principles generally accepted in the United States (GAAP), was $14.6 million, compared to a net loss of $10.9 million in the comparable period in 2007. Alexza had consolidated cash, cash equivalents and marketable securities (including investments held by Symphony Allegro) at March 31, 2008 of $111.7 million.

"The first four months of 2008 have been very productive for Alexza, as we have continued to make progress on all of our product candidates. Importantly, we initiated our first pivotal Phase 3 trial with AZ-004 (Staccato(R) loxapine)," said Thomas B King, President and CEO of Alexza. "We have a comprehensive plan in place to collect the data and other supporting information we will need to submit an NDA for AZ-004. We plan to initiate our second AZ-004 Phase 3 clinical trial in the third quarter of 2008."

Financial Results -- Three Months Ended March 31, 2008 and 2007

GAAP operating expenses were $19.2 million in the first quarter of 2008, compared to $13.8 million for the comparable period in 2007. The first quarter increase resulted from increased spending on AZ-004 and AZ-104 as the Company continued development of these product candidates under the Symphony Allegro agreement, increased spending on AZ-003 with continued development of this product candidate under the development agreement with Endo Pharmaceuticals, increased spending for device development and manufacturi

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore
2. Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008
3. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
4. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
5. Alexzas Corporate Presentation to be Webcast at the 10th Annual BIO CEO & Investor Conference
6. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
7. Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America
8. Alexza Elects Dr. Hal V. Barron to Its Board of Directors
9. 19th Annual Piper Jaffray Health Care Conference to Webcast Alexzas Corporate Presentation
10. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
11. MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments
Post Your Comments:
(Date:10/1/2015)... WORCESTER, Mass. and TORONTO ... ( ) (OTCQB: GNBT) today announced the issuance ... for medicinal purposes and the joint venture between Generex ... design and development of products for the delivery of ... the buccal mucosa (the inner lining of the mouth). ...
(Date:10/1/2015)... 2015  xG Health Solutions, a leading healthcare ... new platform for communication and collaboration with healthcare ... and health plans improve the quality and efficiency ... solutions, products and educational resources. ... clinicians, we know the process of re-engineering care ...
(Date:10/1/2015)... 1, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... in the upcoming Aegis Growth Conference, taking place October ...  Josh Hexter, COO of Oramed, will present a corporate ... Details:   2015 Aegis Growth Conference ...
(Date:10/1/2015)... (PRWEB) , ... October 01, 2015 , ... Mark Seymour, of Radiant Hearth in Potsdam, ... and built a Tulikivi masonry heater for the Mac Kentley family in northern New York. ... that the family's boiler did. One fire is normally enough to keep the home comfortable ...
Breaking Biology Technology:Generex Announces Issuance of Buccal Cannabis White Paper 2Generex Announces Issuance of Buccal Cannabis White Paper 3Generex Announces Issuance of Buccal Cannabis White Paper 4xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2Oramed to Present at the Aegis Capital Growth Conference 2Oramed to Present at the Aegis Capital Growth Conference 3The Masonry Heater Association of North America Receives News About A New York Couple Who Saved Considerable Money Heating Their Home With A Wood Fired Masonry Heater 2
... 15 Congressional Quarterly presents a 360-degree look at ... versions of biotech drugs. This CQ Forum will include ... and leading researchers regarding the complex structures of biologics ... the availability of these products save money for consumers? ...
... Pharmaceuticals, Inc. (Nasdaq: HEPH ), a leader in ... based on endogenous adrenal steroid hormones, today announced the board ... and CEO of Hollis-Eden Pharmaceuticals, Inc. Dr. Frincke was ... , Dr. Frincke joined Hollis-Eden as Vice President, Research and ...
... , HONOLULU, June 15 Nanopoint Inc., an ... products, today announced that effective immediately its cellTRAY ... to the European marketplace. Nanopoint,s cellTRAY Imaging and ... of applications including drug discovery, assisted reproductive technology ...
Cached Biology Technology:Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 2Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 3Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems 2
(Date:9/28/2015)... 28, 2015 The global ... USD 12.03 billion by 2020, growing at a CAGR ... as Backside Illumination (BSI) technique to improve picture quality ... period.      (Logo: , ... to reduce loss and, thus, reduce the noise interference ...
(Date:9/26/2015)... 26th, 2015  Results of a TactioRPM pilot ... today at the Stanford Medicine X Conference. In ... Dashboards, Connected Health Devices and Pharmacogenomics", Roger ... will explain how senior patients equipped with connected ... pharmacist via the TactioRPM remote patient monitoring platform ...
(Date:9/10/2015)... This report provides detailed descriptions of the sensor types ... types that will dominate in the future. Many product ... technology hype curve in the last five years before ... all of them is the prominence of sensor options ... Sensors collect data about the physical and chemical properties ...
Breaking Biology News(10 mins):Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 2Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 3Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 4Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 5Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference 2Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference 3Wearable Sensors 2015-2025: Market Forecasts, Technologies, Players 2
... limited by the seasons, particularly in colder climates ... researchers and fruit breeders, newly developed varieties are ... produce fruit during the offseasonresulting in economic bonuses ... the new varieties of blackberry called "primocane-fruiting", which ...
... The roe of hake, lumpsucker and salmon is the best dietary ... researchers at the University of Almera (UAL). The scientists analysed the ... these contained high levels of these fatty acids, which are essential ... precise understanding of the nutritional potential of the roe of marine ...
... , SAN DIEGO, ... has converted part of an existing building (Keen Hall), including ... cell core facility for the University of California, Riverside. ... , "A key project element was to ensure that although ...
Cached Biology News:New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2Kornberg Associates | Architects Completes UC Riverside Stem Cell Core Facility Project 2